Lodigiani C, et al. – Researchers designed a randomized controlled trial to evaluate whether a low–molecular weight heparin (parnaparin) could affect in vitro fertilization procedures outcomes. The research excludes positive impact of parnaparin, once a day for the whole cycle, on clinical pregnancy rate in infertile women undergoing in vitro fertilization techniques.